Home  |  Contact

Cellosaurus NCI-H69/LX4 (CVCL_2140)

[Text version]

Cell line name NCI-H69/LX4
Synonyms NCI H69-LX4; H69/LX4
Accession CVCL_2140
Resource Identification Initiative To cite this cell line use: NCI-H69/LX4 (RRID:CVCL_2140)
Comments Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Sequence variations Heterozygous for PIK3CA p.Gly106_Arg108del (c.317_325dellGGCAACCGT) (from parent cell line).
Homozygous for RB1 p.Glu748Ter (c.2242G>T) (from parent cell line).
Homozygous for TP53 p.Glu171Ter (c.511G>T) (from parent cell line).
Disease Small cell lung carcinoma (NCIt: C4917)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1579 (NCI-H69)
Sex of cell Male
Age at sampling 55Y
Category Cancer cell line
STR profile Source(s): ECACC

Markers:
AmelogeninX,Y
CSF1PO10,12
D5S81811,13
D7S8209
D13S31712
D16S53911
TH018,9
TPOX10
vWA16,17

Run an STR similarity search on this cell line
Publications

PubMed=3011054; DOI=10.1038/bjc.1986.83
Twentyman P.R., Fox N.E., Wright K.A., Bleehen N.M.
Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
Br. J. Cancer 53:529-537(1986)

PubMed=3034934; DOI=10.1002/jcb.240330405
Ibson J.M., Waters J.J., Twentyman P.R., Bleehen N.M., Rabbitts P.H.
Oncogene amplification and chromosomal abnormalities in small cell lung cancer.
J. Cell. Biochem. 33:267-288(1987)

PubMed=7903701; DOI=10.1093/jnci/86.2.110
Barrand M.A., Heppell-Parton A.C., Wright K.A., Rabbitts P.H., Twentyman P.R.
A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene.
J. Natl. Cancer Inst. 86:110-117(1994)

Cross-references
Cell line collections ECACC; 96042329
Other Wikidata; Q54908107
Entry history
Entry creation04-Apr-2012
Last entry updated25-Feb-2019
Version number13